Free Trial
NYSE:PEN

Penumbra (PEN) Stock Price, News & Analysis

Penumbra logo
$232.26 +3.40 (+1.49%)
Closing price 03:58 PM Eastern
Extended Trading
$232.03 -0.23 (-0.10%)
As of 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Penumbra Stock (NYSE:PEN)

Key Stats

Today's Range
$229.24
$232.91
50-Day Range
$230.10
$296.98
52-Week Range
$148.00
$310.00
Volume
465,798 shs
Average Volume
456,337 shs
Market Capitalization
$9.00 billion
P/E Ratio
219.11
Dividend Yield
N/A
Price Target
$305.07
Consensus Rating
Moderate Buy

Company Overview

Penumbra Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

PEN MarketRank™: 

Penumbra scored higher than 97% of companies evaluated by MarketBeat, and ranked 51st out of 917 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Penumbra has received a consensus rating of Moderate Buy. The company's average rating score is 2.94, and is based on 13 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Penumbra has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Penumbra's stock forecast and price target.
  • Earnings Growth

    Earnings for Penumbra are expected to grow by 36.51% in the coming year, from $3.67 to $5.01 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Penumbra is 219.11, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.38.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Penumbra is 219.11, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.32.

  • Price to Earnings Growth Ratio

    Penumbra has a PEG Ratio of 2.06. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Penumbra has a P/B Ratio of 7.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Penumbra's valuation and earnings.
  • Percentage of Shares Shorted

    5.12% of the float of Penumbra has been sold short.
  • Short Interest Ratio / Days to Cover

    Penumbra has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Penumbra has recently increased by 25.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Penumbra does not currently pay a dividend.

  • Dividend Growth

    Penumbra does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.12% of the float of Penumbra has been sold short.
  • Short Interest Ratio / Days to Cover

    Penumbra has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Penumbra has recently increased by 25.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Penumbra has a news sentiment score of 1.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Penumbra this week, compared to 11 articles on an average week.
  • Search Interest

    10 people have searched for PEN on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Penumbra to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Penumbra insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $31,073,762.00 in company stock.

  • Percentage Held by Insiders

    Only 5.00% of the stock of Penumbra is held by insiders.

  • Percentage Held by Institutions

    88.88% of the stock of Penumbra is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Penumbra's insider trading history.
Receive PEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Penumbra and its competitors with MarketBeat's FREE daily newsletter.

PEN Stock News Headlines

Analysts Set Penumbra, Inc. (NYSE:PEN) PT at $305.07
Altucher: Turn $900 into $108,000 in just 12 months?
Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this marks the beginning of “Trump’s Great Gain,” a new crypto bull phase driven by emerging federal policies. He believes certain altcoins could turn $900 into $108,000 — and reveals everything in a new presentation.
See More Headlines

PEN Stock Analysis - Frequently Asked Questions

Penumbra's stock was trading at $237.48 on January 1st, 2025. Since then, PEN stock has decreased by 2.2% and is now trading at $232.26.

Penumbra, Inc. (NYSE:PEN) released its quarterly earnings results on Wednesday, April, 23rd. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.66 by $0.17. The business's revenue was up 16.3% on a year-over-year basis.
Read the conference call transcript
.

Penumbra's Board of Directors authorized a stock buyback program on Tuesday, August 13th 2024, which allows the company to buy back $200,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 2.6% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its stock is undervalued.

Penumbra's top institutional investors include Congress Asset Management Co. (1.17%), Public Employees Retirement System of Ohio (0.07%), Janney Montgomery Scott LLC (0.06%) and E. Ohman J or Asset Management AB (0.05%). Insiders that own company stock include Arani Bose, Adam Elsesser, Johanna Roberts, Lambert Shiu, Maggie Yuen, Harpreet Grewal, Bridget O'rourke, Thomas Wilder, Surbhi Sarna and Don W Kassing.
View institutional ownership trends
.

Shares of PEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Penumbra investors own include NVIDIA (NVDA), Meta Platforms (META), CrowdStrike (CRWD), Broadcom (AVGO), ServiceNow (NOW), Adobe (ADBE) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
4/23/2025
Today
7/22/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:PEN
CIK
1321732
Employees
4,500
Year Founded
N/A

Price Target and Rating

High Price Target
$340.00
Low Price Target
$260.00
Potential Upside/Downside
+31.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.94
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.06
Trailing P/E Ratio
219.37
Forward P/E Ratio
63.36
P/E Growth
2.06
Net Income
$14.01 million
Net Margins
3.41%
Pretax Margin
4.04%
Return on Equity
11.14%
Return on Assets
8.40%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
6.30
Quick Ratio
3.68

Sales & Book Value

Annual Sales
$1.19 billion
Price / Sales
7.54
Cash Flow
$2.91 per share
Price / Cash Flow
79.81
Book Value
$29.99 per share
Price / Book
7.75

Miscellaneous

Outstanding Shares
38,730,000
Free Float
36,790,000
Market Cap
$9.01 billion
Optionable
Optionable
Beta
0.47

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:PEN) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners